TrialCurrent neuropharmacology2023

Baseline Plasma BDNF Levelsare Associated with Antianhedonic Effects of Repeated-Dose Intravenous Ketamine in Major Depressive Disorder.

Wei Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.